Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting

View source ↗

Summary

A real-world study of guselkumab in adults with psoriatic arthritis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stelara (ustekinumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Psoriatic | Status: RECRUITING